10-QPeriod: Q1 FY2025

ECOLAB INC. Quarterly Report for Q1 Ended Mar 31, 2025

Filed May 8, 2025For Securities:ECL

Summary

Ecolab Inc. reported first-quarter 2025 results with net sales of $3,695.0 million, a 2% decrease compared to the prior year, primarily due to the divestiture of the global surgical solutions business and unfavorable currency translation. However, on a fixed currency basis, net sales increased by 1%, and organic sales grew by 3%. The company's operating income saw a healthy increase of 7% to $555.3 million, driven by strong organic growth across its segments and improved pricing strategies. Net income attributable to Ecolab was $402.5 million, a slight decrease of 2% year-over-year, while diluted EPS stood at $1.41. The company continues to make progress on its 'One Ecolab' initiative, which is designed to enhance growth and margin expansion, with significant restructuring charges impacting the current quarter. Despite these charges and ongoing macroeconomic uncertainties, Ecolab's diversified business model and focus on value pricing have supported its performance. Investors will be watching the execution of the 'One Ecolab' plan and its impact on future profitability and cash flow generation.

Financial Highlights

53 data points
Beta

Revenue

$3.69B

44.2% Gross Margin

Net Income

$402.50M

10.9% Net Margin

EPS (Diluted)

$1.41

Total Assets

$22.37B

Cash & Equivalents

$1.16B

Free Cash Flow

$131.50M

Financial Statements
Beta
Revenue$3.69B
Cost of Revenue$2.06B
Gross Profit$1.63B
SG&A Expenses$1.05B
Operating Income$555.30M
Interest Expense$72.60M
Net Income$402.50M
EPS (Basic)$1.42
EPS (Diluted)$1.41
Shares Outstanding (Basic)283.40M
Shares Outstanding (Diluted)285.30M

Key Highlights

  • 1Net sales decreased 2% to $3,695.0 million, but organic sales increased by 3% year-over-year.
  • 2Operating income increased 7% to $555.3 million, with organic operating income up 17%.
  • 3Net income attributable to Ecolab decreased by 2% to $402.5 million ($1.41 diluted EPS).
  • 4The company is progressing with its 'One Ecolab' restructuring initiative, incurring $39.4 million in charges during the quarter.
  • 5Gross margin improved to 44.2% from 43.3% in the prior year, driven by strong value pricing.
  • 6The Global Water segment reported a 3% increase in fixed currency sales and a 7% increase in fixed currency operating income.
  • 7The company's revolving credit facility maturity was extended to March 2030, and it maintained a strong liquidity position with $1,162.6 million in cash and cash equivalents.

Frequently Asked Questions

The reported net sales decrease of 2% to $3,695.0 million was primarily driven by the divestiture of the global surgical solutions business and unfavorable currency translation effects.

The 'One Ecolab' initiative led to $39.4 million in restructuring charges during the first quarter of 2025, primarily related to severance costs. While these charges impacted net income, the initiative is expected to enhance future growth and margin expansion.

Ecolab maintains a strong liquidity position with $1,162.6 million in cash and cash equivalents as of March 31, 2025. The company also extended its revolving credit facility maturity to March 2030 and has ample borrowing capacity to meet its foreseeable needs.

Most segments showed positive organic growth. Global Water's fixed currency sales increased 3%, Global Institutional & Specialty's organic sales grew 4%, Global Pest Elimination's organic sales increased 5%, and Global Life Sciences' organic sales rose 5%. Operating income also saw increases in most segments on a fixed currency or organic basis.